Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Day

Showing results (51-60 of 501) with videos related to

Pageof 51
Sort By:
The Medical Journal of Australia|June 4, 2023
Avoiding severe drug hypersensitivity reactions: a case for HLA genotyping for at-risk patientsJana Stojanova, Richard O Day, Graeme Suthers
The Medical Journal of Australia|April 5, 2012
Time for the Pharmaceutical Benefits Advisory Committee to set its own agendaWendy L Lipworth, Ian Kerridge, Richard O Day
Nature|January 31, 1975
Nucleic acid-mutagen interactions: crystal structure of adenylyl-3',5'-uridine plus 9-aminoacridineN C Seeman, R O Day, A Rich
Emergency Medicine Australasia : EMA|June 15, 2007
Utility of urine drug screening: a clinical auditBridin P Murnion, Ron Granot, Richard O Day
British Journal of Clinical Pharmacology|May 13, 1998
Indicators for drug and therapeutics committeesL M Weekes, C Brooks, R O Day
International Journal of Medical Informatics|April 28, 2015
Identifying effective computerized strategies to prevent drug-drug interactions in hospital: A user-centered approachOlivia Missiakos, Melissa T Baysari, Richard O Day
The Journal of Prosthetic Dentistry|May 1, 1980
Clinical considerations for root-submergence proceduresP Delivanis, O Day, C Esposito, et al.
Nature Reviews. Rheumatology|September 30, 2015
Allopurinol hypersensitivity: investigating the cause and minimizing the riskLisa K Stamp, Richard O Day, James Yun
Emergency Medicine Australasia : EMA|June 18, 2019
Role and impact of brain computed tomography in the management of drug overdoses and guideline recommendationsEmma My Tay, Paul Preisz, Richard O Day
Free Radical Research Communications|January 1, 1993
Identification of products from oxidation of uric acid induced by hydroxyl radicalsM Hicks, L S Wong, R O Day
Pageof 51

Showing results (51-60 of 501) with videos related to

Sort By:
Pageof 51
The Medical Journal of Australia|June 4, 2023
Avoiding severe drug hypersensitivity reactions: a case for HLA genotyping for at-risk patientsJana Stojanova, Richard O Day, Graeme Suthers
The Medical Journal of Australia|April 5, 2012
Time for the Pharmaceutical Benefits Advisory Committee to set its own agendaWendy L Lipworth, Ian Kerridge, Richard O Day
Nature|January 31, 1975
Nucleic acid-mutagen interactions: crystal structure of adenylyl-3',5'-uridine plus 9-aminoacridineN C Seeman, R O Day, A Rich
Emergency Medicine Australasia : EMA|June 15, 2007
Utility of urine drug screening: a clinical auditBridin P Murnion, Ron Granot, Richard O Day
British Journal of Clinical Pharmacology|May 13, 1998
Indicators for drug and therapeutics committeesL M Weekes, C Brooks, R O Day
International Journal of Medical Informatics|April 28, 2015
Identifying effective computerized strategies to prevent drug-drug interactions in hospital: A user-centered approachOlivia Missiakos, Melissa T Baysari, Richard O Day
The Journal of Prosthetic Dentistry|May 1, 1980
Clinical considerations for root-submergence proceduresP Delivanis, O Day, C Esposito, et al.
Nature Reviews. Rheumatology|September 30, 2015
Allopurinol hypersensitivity: investigating the cause and minimizing the riskLisa K Stamp, Richard O Day, James Yun
Emergency Medicine Australasia : EMA|June 18, 2019
Role and impact of brain computed tomography in the management of drug overdoses and guideline recommendationsEmma My Tay, Paul Preisz, Richard O Day
Free Radical Research Communications|January 1, 1993
Identification of products from oxidation of uric acid induced by hydroxyl radicalsM Hicks, L S Wong, R O Day
Pageof 51